Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunovant, Inc.

14.89
-0.3500-2.30%
Post-market: 14.79-0.1000-0.67%18:17 EDT
Volume:955.99K
Turnover:14.31M
Market Cap:2.60B
PE:-5.25
High:15.36
Open:15.26
Low:14.81
Close:15.24
52wk High:34.47
52wk Low:12.72
Shares:174.32M
Float Shares:66.98M
Volume Ratio:0.76
T/O Rate:1.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8352
EPS(LYR):-2.7303
ROE:-77.58%
ROA:-47.07%
PB:4.27
PE(LYR):-5.45

Loading ...

Feb 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 02, 2021

Major Issues Report

8-K - Current report
Jan 12, 2021

Correspondence

CORRESP [Cover] - Correspondence
Nov 12, 2020

Major Issues Report

8-K - Current report
Nov 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 18, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 18, 2020

Major Issues Report

8-K - Current report
Sep 04, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 31, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 31, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 31, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Aug 25, 2020

Major Issues Report

8-K - Current report
Aug 21, 2020

Major Issues Report

8-K - Current report
Aug 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2020

Major Issues Report

8-K - Current report
Jun 30, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 29, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jun 29, 2020

Major Issues Report

8-K - Current report
Jun 15, 2020

Delisting

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
May 15, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership